Edition:
United States

Trinity Biotech PLC (TRIB.OQ)

TRIB.OQ on NASDAQ Stock Exchange Global Select Market

5.87USD
25 Apr 2017
Change (% chg)

-- (--)
Prev Close
$5.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
20,612
52-wk High
$13.65
52-wk Low
$5.29

TRIB.OQ

Chart for TRIB.OQ

About

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the... (more)

Overall

Beta: 1.18
Market Cap(Mil.): $141.12
Shares Outstanding(Mil.): 24.04
Dividend: --
Yield (%): --

Financials

  TRIB.OQ Industry Sector
P/E (TTM): 79.80 29.33 30.27
EPS (TTM): 0.07 -- --
ROI: 0.91 13.69 13.24
ROE: 1.46 14.64 14.40

BRIEF-Lapides Asset Management LLC reports 5.1 pct passive stake in Trinity Biotech

* Lapides Asset Management LLC reports 5.1 percent passive stake in trinity Biotech Plc as of March 6 - sec filing Source text : http://bit.ly/2msqjyg Further company coverage:

Mar 15 2017

BRIEF-Trinity Biotech quarterly EPS $0.043

* Trinity biotech announces quarter 4 and fiscal year 2016 financial results

Mar 14 2017

BRIEF-Stonepine Capital LP reports 6.2 pct passive stake in Trinity Biotech

* Stonepine Capital LP reports 6.2 percent passive stake in Trinity Biotech Plc as of October 14 - sec filing Source text : http://bit.ly/2f1bxvS Further company coverage:

Nov 02 2016

More From Around the Web

Competitors

Earnings vs. Estimates